Presentation is loading. Please wait.

Presentation is loading. Please wait.

Superior sulcus (Pancoast) tumor: experience with 105 patients

Published byJuliet York Modified over 5 years ago

Similar presentations

Presentation on theme: "Superior sulcus (Pancoast) tumor: experience with 105 patients"— Presentation transcript:

1 Superior sulcus (Pancoast) tumor: experience with 105 patients
Safuh Attar, MD, Mark J Krasna, MD, Joshua R Sonett, MD, John R Hankins, MD, Robert G Slawson, MD, Charles M Suter, PhD, Joseph S McLaughlin, MD  The Annals of Thoracic Surgery  Volume 66, Issue 1, Pages (July 1998) DOI: /S (98)

2 Fig 1 Distribution of the five treatment groups. (Pre-op Rad + Surg = preoperative radiation and operation [group I]; Surg + Post-op Rad = operation and postoperative radiation [group II]; Radiation = radiation therapy only [group III]; Chemo + Rad Surg = preoperative chemotherapy, radiation therapy, and operation [group IV]; and Surg = operation only [group V].) The Annals of Thoracic Surgery  , DOI: ( /S (98) )

3 Fig 2 Five-year and 10-year survival curve for 104 patients.
The Annals of Thoracic Surgery  , DOI: ( /S (98) )

4 Fig 3 Median survival and 5-year survival in all five groups.
The Annals of Thoracic Surgery  , DOI: ( /S (98) )

5 Fig 4 Comparison of median and 5-year survival in patients with T3 and T4 tumors. The Annals of Thoracic Surgery  , DOI: ( /S (98) )

6 Fig 5 Comparison of length of survival according to lymph node stage.
The Annals of Thoracic Surgery  , DOI: ( /S (98) )

Download ppt "Superior sulcus (Pancoast) tumor: experience with 105 patients"

Similar presentations

Photodynamic Laser Therapy for Lesions in the Airway

Photodynamic Laser Therapy for Lesions in the Airway
Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery  Michael E. Halkos, MD,

Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery  Michael E. Halkos, MD,
Elizabeth A. David, MD, David T

Elizabeth A. David, MD, David T
Primary non-Hodgkin’s lymphoma of the lung

Primary non-Hodgkin’s lymphoma of the lung
Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection  Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.

Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection  Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.
Stroke after coronary artery operation: incidence, correlates, outcome, and cost  John D Puskas, MD, A.Daniel Winston, MD, Carolyn E Wright, MS, John Parker.

Stroke after coronary artery operation: incidence, correlates, outcome, and cost  John D Puskas, MD, A.Daniel Winston, MD, Carolyn E Wright, MS, John Parker.
Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival  Elizabeth A. David, MD, Robert J. Canter,

Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival  Elizabeth A. David, MD, Robert J. Canter,
Now or Later: Evaluating the Importance of Chemotherapy Timing in Resectable Stage III (N2) Lung Cancer in the National Cancer Database  Daniel J. Boffa,

Now or Later: Evaluating the Importance of Chemotherapy Timing in Resectable Stage III (N2) Lung Cancer in the National Cancer Database  Daniel J. Boffa,
Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients  Ze Fen Xiao, MD, Zong Yi Yang, MD, Jun Liang, MD, Yan.

Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients  Ze Fen Xiao, MD, Zong Yi Yang, MD, Jun Liang, MD, Yan.
Joshua E. Rosen, BASc, Hari B

Joshua E. Rosen, BASc, Hari B
Immunology and failure of valved allografts in children

Immunology and failure of valved allografts in children
Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers  Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.

Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers  Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.
Lung cancer staging and treatment in multidisciplinary trials: cancer and leukemia group B cooperative group approach1  Mark J Krasna, MD, Carolyn E Reed,

Lung cancer staging and treatment in multidisciplinary trials: cancer and leukemia group B cooperative group approach1  Mark J Krasna, MD, Carolyn E Reed,
Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A

Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer  Yoshinori Handa, MD, Yasuhiro Tsutani, MD, PhD, Norifumi Tsubokawa,

Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer  Yoshinori Handa, MD, Yasuhiro Tsutani, MD, PhD, Norifumi Tsubokawa,
Lung Cancer Staging: A Case for a New T Definition

Lung Cancer Staging: A Case for a New T Definition
Kazumichi Yamamoto, MD, Satoshi Kosaba, MD, Toshikazu Ikeda, PhD 

Kazumichi Yamamoto, MD, Satoshi Kosaba, MD, Toshikazu Ikeda, PhD 
Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Similar presentations

Ads by Google